Innovation, influence and business in America's medical cities.

Baxter International Inc. (NYSE:BAX) named Ludwig Hantson president of its international operations, effective May 3.The Deerfield, Ill.-based medical products conglomerate said expanding its global footprint is a “key growth driver” for the company.Hantson’s pedigree is stamped by years in the pharmaceutical industry. He was CEO of Novartis Pharmaceuticals Corp.’s (NYSE:NVS) Pharma [...]

Zimmer Holdings Inc. (NYSE:ZMH) brought in a new president to lead its global business unit. Former Stryker Corp. (NYSE:SYK) executive Jeffrey Paulsen will lead the Warsaw, Ind.-based orthopedics giant’s international operations.

Thirty-two year hospital veteran Kevin Miller is scheduled to begin a three-year term with the Ohio Hospital Association’s board of trustees in January.

The consumer health services provider has appointed former Indianapolis mayor Stephen Goldsmith to sit on its board of directors.

M. Steven Jones begins Monday as president in Geauga County, on the eastern border of Cleveland’s Cuyahoga County. He served as the vice president there and earlier was vice president of the health systems’ musculoskeletal and neuroscience services at UH.

Brett S. Himes takes over for former chief executive Jerry C. Cirino, who left sister company Reichert. Reichert, which makes devices for the eye-care industry, is owned by Beecken Petty O’Keefe & Company, which also own Heartland. Cirino remains on the Heartland’s board.

Michael Fisher will take over for longtime leader Jim Anderson who is leaving at year’s end. Fisher spent five years on the hospital board and also for a time lead the Cincinnati USA Regional Chamber of Commerce.

The primary purpose of the vice president for the Battelle/Ohio State collaboration is helping with “idea generation, development and implementation” and to create a “more robust” set of joint research and economic development ventures.

CWRU medical school Dean Dr. Pamela B. Davis and CSU bioethics law professor Dena S. Davis are members of a nine-member Working Group for Human Embryonic Stem Cell Eligibility Review.

Dr. A. Marc Gillinov, who leads the Cleveland Clinic’s Center for Atrial Fibrillation, has joined the scientific advisory board of the New Jersey device company Endovalve.